The Antitrust Review of the Americas 2019

Global Competition Review

High-tech antitrust enforcement is at the top of the Trump administration antitrust enforcement agenda, including challenges to mergers affecting technology platforms and the pharma and life sciences industries. Statements by senior leadership at both the US Department of Justice and US Federal Trade Commission promise vigorous enforcement in tech and pharma industries, and recent actions against transactions, including non-reportable deals, prove they are serious.

Read the article

Related Contacts
Megan Browdie  Partner Washington, DC
Jacqueline Grise  Partner Washington, DC
Howard Morse  Partner Washington, DC
Julia R. Brinton  Associate Washington, DC
Related Practices & Industries

Antitrust & Competition  Mergers & Acquisitions